Impact of substance abuse on the course and outcome of schizophrenia
- PMID: 2185537
- DOI: 10.1093/schbul/16.1.87
Impact of substance abuse on the course and outcome of schizophrenia
Abstract
Numerous pharmacological agents have been shown to have powerful effects on cognitive behavior. Schizophrenia-like reactions have been reported in some instances. There have also been persistent reports of drug abuse among psychiatric patients before and during hospitalization. These phenomena have led to speculation that psychoactive substances are affecting the course and outcome of psychiatric illnesses, and in particular, schizophrenia. This report first reviews the evidence for psychotomimetic effects of various drugs, and then focuses on reports of the effect that substance abuse has on the course of schizophrenia and long-term outcome. The evidence to date indicates that there is a need for a large epidemiological analysis of the interplay between drug abuse and schizophrenia as well as more intensive case studies of afflicted individuals. This discussion concludes with suggestions for improved research methods and two designs for future investigations.
Similar articles
-
Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports.Schizophr Bull. 1990;16(1):69-79. doi: 10.1093/schbul/16.1.69. Schizophr Bull. 1990. PMID: 2185536 Review.
-
Schizophrenia and substance abuse.Psychiatr Clin North Am. 1993 Jun;16(2):401-12. Psychiatr Clin North Am. 1993. PMID: 8332568 Review.
-
[Addiction and schizophrenia. Nosological, clinical and therapeutic questions. 2. Substance dependence and schizophrenia].Fortschr Neurol Psychiatr. 1994 Jun;62(6):186-96. doi: 10.1055/s-2007-996671. Fortschr Neurol Psychiatr. 1994. PMID: 8050773 Review. German.
-
[Do alcohol or drug abuse induce schizophrenia?].Nervenarzt. 1996 Jan;67(1):36-45. Nervenarzt. 1996. PMID: 8676987 German.
-
Drug induced psychosis.Br J Psychiatry. 1996 Feb;168(2):135-8. doi: 10.1192/bjp.168.2.135. Br J Psychiatry. 1996. PMID: 8837900 Review. No abstract available.
Cited by
-
Schizophrenia and the life cycle.Community Ment Health J. 1995 Jun;31(3):249-62. doi: 10.1007/BF02188751. Community Ment Health J. 1995. PMID: 7621662 Review.
-
Enhanced brain disposition and effects of Δ9-tetrahydrocannabinol in P-glycoprotein and breast cancer resistance protein knockout mice.PLoS One. 2012;7(4):e35937. doi: 10.1371/journal.pone.0035937. Epub 2012 Apr 20. PLoS One. 2012. PMID: 22536451 Free PMC article.
-
Prevalence of alcohol and drug abuse in schizophrenic inpatients.Eur Arch Psychiatry Clin Neurosci. 1993;242(6):362-72. doi: 10.1007/BF02190250. Eur Arch Psychiatry Clin Neurosci. 1993. PMID: 8323987 Review.
-
The endocannabinoid system as an emerging target of pharmacotherapy.Pharmacol Rev. 2006 Sep;58(3):389-462. doi: 10.1124/pr.58.3.2. Pharmacol Rev. 2006. PMID: 16968947 Free PMC article. Review.
-
Thioridazine for schizophrenia.Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD001944. doi: 10.1002/14651858.CD001944.pub2. Cochrane Database Syst Rev. 2007. PMID: 17636691 Free PMC article.